Forecasts data is unavailable for this security.
Consensus recommendation
- 15-Jun-23
- 14-Mar-24
- 18-Apr-24
- 16-May-24
Select bar for recommendation details.
Recommendations | 16-May-24 | |
---|---|---|
Buy | 3 | |
Outperform | 3 | |
Hold | 6 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for Hikma Pharmaceuticals Plc have a median target of 2,214.36, with a high estimate of 2,763.23 and a low estimate of 1,875.44. The median estimate represents a 14.20% increase from the last price of 1,939.00.
High | 42.5% | 2,763.23 |
Med | 14.2% | 2,214.36 |
Low | -3.3% | 1,875.44 |
Dividends in USD
Div growth (TTM) | 30.11% |
---|
More ▼
Earnings history & estimates in USD
Average growth rate | +10.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | +6.99% |
More ▼